Pharmacists practising in a community setting see patients of all ages suffering from allergic rhinitis or urticaria (hives) on a regular basis. Although differing in clinical presentation, these allergic conditions share pathogenesis. Hence the treatment approaches are similar. Being aware of the most updated Canadian and international guidelines will help community pharmacists prescribe or recommend the appropriate treatment for children and adults and manage the symptoms of both allergic rhinitis and urticaria.
This continuing education course for pharmacists is approved by CCCEP for 1.0 credits. Course # 1329-2023-3615-I-P.
Supported by educational funding from Aralez Pharmaceuticals Canada Inc.
Learning objectives
Upon successful completion of this continuing education lesson, pharmacists will be better able to:
- Discuss the pathophysiology of allergic rhinitis (AR) and chronic spontaneous urticaria (CSU).
- Compare and contrast the prescription antihistamines available for AR and CSU.
- Recommend/Prescribe appropriate prescription antihistamine therapy for patients with AR and CSU based on Canadian and International guidelines in both pediatric patients and adults.
- Provide appropriate education to improve patient self-efficacy in dealing with allergic rhinitis and chronic spontaneous urticaria.
Course author: Roger Tam BSc. Pharm. CDE CTE PM2 (he/him)
This continuing education is free for members of CanadianHealthcareNetwork.ca. Log in and click here to take the course: